EPA Facing More Litigation on Legacy Asbestos

The Asbestos Disease Awareness Organization delivered on an earlier notice of intent to sue by filing an official complaint against the U.S. Environmental Protection Agency over its ongoing risk evaluation of asbestos. ADAO, a leading nonprofit aimed at preventing asbestos exposure, was joined by five other organizations and several public health experts in asking the court to set a deadline for the EPA to complete its work. The lawsuit was filed May 18 in the U.S. Northern District of California Court in San Francisco. The notice of intent to sue  was delivered in January. Thoracic surgeon Dr. Raja Flores of Mount Sinai Hospital, a New York City mayoral candidate, is among the health experts listed as plaintiffs. Michael Regan, EPA administrator, is the defendant. Exposure to asbestos, a naturally occurring mineral once used ubiquitously in construction, can cause a number of serious health issues, including mesothelioma cancer. The lawsuit contends that the EPA has failed to adequately evaluate asbestos as required by the amended Toxic Substances Control Act. “One thing for sure, the U.S. can’t manage the existing risk of legacy asbestos, nor imports and use,” Linda Reinstein, ADAO president and co-founder, told The Mesothelioma Center at Asbsestos.com. “Americans can’t wait any longer. Our country has been remiss in protecting Americans from harm.” Asbestos Final Risk Evaluation Found Lacking The lawsuit was spa...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news

Related Links:

.
Source: Nutrition and Cancer - Category: Cancer & Oncology Authors: Source Type: research
Imagine a world in which physicians can confidently cure cancer. Two Bay Area life sciences companies are working together to make this vision a reality. Atara Biotherapeutics Inc., founded in 2012, is developing a pipeline of cell therapies to treat various types of cancer and autoimmune diseases. Bayer is licensing Atara’s cutting-edge cell therapies that t arget certain types of aggressive tumors including mesothelioma, pancreatic, ovarian and non-small-cell lung cancer. “With cancer therapies,…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news
The 16th Annual International Asbestos Awareness and Prevention Conference takes place Sept. 17-18, featuring 40 speakers from seven countries plus the first-ever Art, Advocacy and Shared Stories film festival. This virtual event is open to all free of charge, requiring only an online registration. It is designed to educate the public about the dangers of asbestos, intensify efforts to ban asbestos, and aid in research to improve treatment for asbestos diseases, including mesothelioma cancer. Sponsoring the event is the Asbestos Disease Awareness Organization, an independent nonprofit regarded as the world’s le...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
This study, performed during the pre-vaccine period of the pandemic, once again demonstrates the importance of vaccination against COVID-19,” said Dr. Susana Cedres, a medical oncologist with Vall d’Hebron Hospital. “Malignant pleural mesothelioma patients are particularly vulnerable to COVID-19.” Cedres said since the subsequent rollout of the COVID-19 vaccines, no positive cases have been attributed to pleural mesothelioma patients at the hospital. The average age of the seven patients was 62. All had the epithelioid histology of mesothelioma and two were receiving oncologic treatment at the...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
Malignant pleural mesothelioma is a rare cancer, but one of the most frequent occupational malignant diseases. We evaluated the annual health care costs and changes in costs in Finland 2002 –2012. Compared with the average health care costs, the total costs and the cost per patient were growing 2-fold faster in mesothelioma patients. Only a proportion of healthcare costs were charged appropriately Workers' Compensation Insurance. AbstractBackgroundSubstantial variation in health care costs for malignant pleural mesothelioma (MPM) has previously been identified.Materials and MethodsWe analyzed the changes in health ca...
Source: Thoracic Cancer - Category: Cancer & Oncology Authors: Tags: ORIGINAL ARTICLE Source Type: research
Adding the drug ramucirumab to gemcitabine chemotherapy worked especially well in a recent clinical trial involving second-line treatment for patients with pleural mesothelioma. Ramucirumab, an immunotherapy drug also known by the brand name Cyramza, is a monoclonal antibody that works by targeting and restricting a protein that stimulates blood vessel growth within tumors. Impressive results in the phase II clinical trial moved the drug combination closer to filling the long-standing void for a second-line mesothelioma treatment. The Lancet Oncology recently published results of the study, which was conducted in ...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
World J Clin Oncol. 2021 Aug 24;12(8):581-608. doi: 10.5306/wjco.v12.i8.581.ABSTRACTMalignant pleural mesothelioma (MPM) is a rare tumor with poor prognosis and rising incidence. Palliative care is common in MPM as radical treatment with curative intent is often not possible due to metastasis or extensive locoregional involvement. Numerous therapeutic advances have been made in recent years, including the use of less aggressive surgical techniques associated with lower morbidity and mortality (e.g., pleurectomy/decortication), technological advancements in the field of radiotherapy (intensity-modulated radiotherapy, image-...
Source: Clinical Lung Cancer - Category: Cancer & Oncology Authors: Source Type: research
Cancers, Vol. 13, Pages 4580: Hyperthermic Intrathoracic Chemotherapy (HITOC) after Cytoreductive Surgery for Pleural Malignancies—A Retrospective, Multicentre Study Cancers doi: 10.3390/cancers13184580 Authors: Michael Ried Julia Kovács Till Markowiak Karolina Müller Gunnar Huppertz Michael Koller Hauke Winter Laura V. Klotz Rudolf Hatz Julia Zimmermann Bernward Passlick Severin Schmid Mohamed Hassan Martin E. Eichhorn Hans-Stefan Hofmann In the context of quality assurance, the objectives were to describe the surgical treatment and postoperative morbidity (particularl...
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Article Source Type: research
Dr. David Prezant was knocked fully airborne at 9:59 on the morning of Sept. 11, 2001. He didn’t see the impact coming, but he felt it when it hit—and it nearly killed him. Little more than an hour earlier, Prezant, then the deputy chief medical officer of the Fire Department of New York, was headed for his usual workplace at the FDNY’s Office of Medical Affairs, just across the Manhattan Bridge in Brooklyn. He had already heard that a plane had hit the North Tower of the World Trade Center, and he reckoned that it was an accident. By the time he reached his office, however, the South Tower had been struc...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized healthscienceclimate Source Type: news
A recent report from the Fire Department of New York World Trade Center Health Program outlines the 9/11-related health effects firefighters are dealing with 20 years later. Approximately 410,000 first responders spent the days and weeks after 9/11 inhaling toxic materials as they helped save lives from the collapse of the Twin Towers. Almost 3,000 people died on Sept. 11, 2001, but in the 20 years since, another 4,343 survivors have died due to related health effects. FDNY has felt the impact of delayed illness, as well. While 343 FDNY firefighters died on 9/11, another 254 have died since then from 9/11-related dis...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
More News: Asbestosis | Cancer | Cancer & Oncology | Cardiovascular & Thoracic Surgery | Chemistry | Education | Environmental Health | Hospitals | International Medicine & Public Health | Lawsuits | Legislation | Mesothelioma | Occupational Health | Politics | Small Businesses | Toxicology | Universities & Medical Training